Table 3.
Dosage of Granzyme G Morpholino | Total embryo treated in one-cell stage† | No. (%) of survival embryo after treatment | No. (%) of embryos developed to | ||||
---|---|---|---|---|---|---|---|
2-cell embryo | 4-cell embryo | 8-cell embryo | Morula embryo | Blastocyst embryo | |||
2 mM | 64 | 31(48.4) | 25(80.7)a | 7(22.6)a | 0(0.0)a | 0(0.0)a | 0(0.0)a |
0.2 mM | 65 | 33(50.8) | 32(97.0) b | 29(87.9)b | 25(75.8)b | 24(72.7)b | 11(33.3)b |
0.02 mM | 81 | 45(55.6) | 45(100.0)b | 45(100.0)c | 43(95.6)c | 43(95.6)c | 43(95.6)c |
0.002 mM | 63 | 39(61.9) | 38(97.4)b | 36(92.3)bc | 34(87.2)bc | 34(87.2)bc | 34(87.2)c |
† Six experiments were carried out in each group, and 10-15 embryos were used in each experiment.
abc Different superscripts within a column indicate a statistically significant difference (p < 0.05).